Immunization

Investigators from the CDC Human Papillomavirus (HPV) Vaccine Impact Monitoring Project (HPV-IMPACT) sought to determine whether HPV types 16 and 18, which are responsible for approximately 70% of cervical cancers worldwide, are also decreasing.

The agency urges the public to receive a vaccine if they have not already done so.

For this edition of Throwback Thursday, we look back in time at Jonas Salk and his research.

The findings reinforce the effectiveness of the HPV vaccine in preventing cervical cancer.

Why is this patient requesting the flu vaccine in the middle of June?

Study findings also suggest a path forward to create even more effective flu vaccines.

Immunizations lower the risk of cardiovascular complications, preventing serious illnesses and saving lives.

Writing in The Journal of Infectious Disease, they noted that pregnant women tend to be treated as high-priority patients when it comes to influenza prevention and treatment, but they said there is relatively little evidence clarifying exactly how outcomes differ for pregnant women versus nonpregnant women.

Top news of the day across the health care landscape.

The flu vaccine prevented 7.1 million illnesses, according to the analysis, along with 109,000 hospitalizations, and 8000 deaths, during the 2017-2018 influenza season.

Amid a global measles outbreak, some teenagers are questioning their anti-vaxxer parents about not vaccinating them against many dangerous and deadly diseases.

Throughout the country, 47 states and Puerto Rico experienced this in the week ended February 2.

Zoster vaccine recombinant, adjuvanted (Shingrix, GlaxoSmithKline) was approved in October 2017 for the prevention of the viral infection in adults 50 and older.

At least 79 individual cases of measles in the United States have been reported since the start of 2019.

Rite Aid pharmacies are providing measles-mumps-rubella (MMR) vaccinations in 2 states that are seeing an increase in reported measles cases.

Pharmacists Should Carefully Screen for Contraindications and Precautions Before Immunizing Patients.

Overall, 3.1% of people in the United States sought treatment from their health care providers for flu-like illness during the week ended January 12, 2019.

Healthy People 2020 Goals Prove Elusive, but Pharmacists Can Advocate, Educate, Identify, and Immunize.

The most effective interventions in patients are multifaceted, not singly focused.

Measles outbreaks are on the rise globally, and it is considered a public health crisis.

The FDA has approved Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Tdap) use to include repeat vaccination to help protect against tetanus, diphtheria and pertussis.

This vaccine does not constitute a primary immunization series against pertussis.

This is the only vaccination approved in the United States to prevent this bacterial disease.

Influenza vaccinations among patients with diabetes rose by 20% when they were notified about scheduling their flu shot, according to a new study.

A new report published in the CDC Morbidity and Mortality Weekly Report (MMWR) has linked cases of acute hepatitis A virus (HAV) infections from certain states to person-to-person transmission from drug use or homelessness.

Findings showed that LAIV was more effective in those vaccinated in both the enrollment season and the prior season than in those vaccinated only in the enrollment season.

Although HPV vaccination rates have steadily increased in recent years, more work is needed in this area to effectively reduce HPV-associated cancer, according to a new report release by the President’s Cancer Panel.

Flu season has arrived once again, and pharmacists across the country are gearing up to provide patients with vaccines to prevent influenza and medications to treat it.

Officials with the FDA have approved baloxavir marboxil (Xofluza, Shionogi) for the treatment of acute uncomplicated influenza in patients aged 12 years and older who have been symptomatic for no more than 48 hours.

The vaccine, produced by Seqirus, was first approved in the United States in August 2016 for adults 18 and older.